fluorodeoxyglucose f18 has been researched along with Adenoma, Prostatic in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (25.00) | 18.2507 |
2000's | 2 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (25.00) | 2.80 |
Authors | Studies |
---|---|
Chang, H; Joo, KJ; Kim, SJ; Kim, YH; Ryu, S; Youn, I | 1 |
Arzumanov, AA; Karelin, MI; Ryzhkova, DV; Shkol'nik, MI; StanzhevskiÄ, AA; Tlostanova, MS | 1 |
Arzumanov, AA; Granov, AM; Karelin, MI; Kostenikov, NA; Ryzhkova, DV; Shkol'nik, MI; StanzhevskiÄ, AA; Tlostanova, MS | 1 |
Akino, H; Kanamaru, H; Okada, K; Oyama, N; Sadato, N; Suzuki, Y; Yonekura, Y | 1 |
4 other study(ies) available for fluorodeoxyglucose f18 and Adenoma, Prostatic
Article | Year |
---|---|
Association between prostatic 18F-FDG uptake and lower urinary tract symptoms assessed by International Prostate Symptom Score.
Topics: Fluorodeoxyglucose F18; Humans; Inflammation; Lower Urinary Tract Symptoms; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Prostate; Prostatic Hyperplasia | 2022 |
[Positron emission tomography with 18-fluorine deoxyglucose in the diagnosis and assessment of prostate cancer].
Topics: Aged; Chronic Disease; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Positron-Emission Tomography; Predictive Value of Tests; Prostatic Hyperplasia; Prostatic Neoplasms; Prostatitis; Radiopharmaceuticals; Ultrasonography; Whole-Body Irradiation | 2008 |
[Positron emission tomography in oncourology].
Topics: Adolescent; Adult; Aged; Carcinoma, Embryonal; Carcinoma, Renal Cell; Choriocarcinoma; Data Interpretation, Statistical; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Kidney; Kidney Neoplasms; Lymph Node Excision; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Metastasis; Positron-Emission Tomography; Prostate; Prostate-Specific Antigen; Prostatic Hyperplasia; Prostatic Neoplasms; Radiopharmaceuticals; Seminoma; Sensitivity and Specificity; Testicular Neoplasms; Testis | 2005 |
The increased accumulation of [18F]fluorodeoxyglucose in untreated prostate cancer.
Topics: Aged; Aged, 80 and over; Combined Modality Therapy; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Prospective Studies; Prostate; Prostate-Specific Antigen; Prostatic Hyperplasia; Prostatic Neoplasms; Radiopharmaceuticals; Tomography, Emission-Computed | 1999 |